Bristol-Myers Patent Win Over Gilead Grows to $1.2 Billion

(Bloomberg) -- Bristol-Myers Squibb Co. persuaded a judge to boost damages to $1.2 billion in its patent-infringement case against Gilead Sciences Inc.’s Kite unit over revolutionary treatments tha...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.